Costs and Benefits of Including Inactivated in Addition to Oral Poliovirus Vaccine in Outbreak Response After Cessation of Oral Poliovirus Vaccine Use

Background: After stopping serotype 2–containing oral poliovirus vaccine use, serotype 2 poliovirus outbreaks may still occur and require outbreak response supplemental immunization activities (oSIAs). Current oSIA plans include the use of both serotype 2 monovalent oral poliovirus vaccine (mOPV2) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Duintjer Tebbens, Radboud J., Thompson, Kimberly M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124926/
https://www.ncbi.nlm.nih.gov/pubmed/30288417
http://dx.doi.org/10.1177/2381468317697002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124926/
https://www.ncbi.nlm.nih.gov/pubmed/30288417
http://dx.doi.org/10.1177/2381468317697002

Ejemplares similares